Antibiotic Therapy

ANAHEIM, Calif. — An antimicrobial stewardship initiative involving more than 130 U.S. hospitals has shown promise — particularly when it comes to treating children for an appropriate duration, researchers reported here.

Data from a dozen states suggest that norovirus cases are rebounding, likely because Americans are not taking the same level of precautions to prevent COVID-19 as they did earlier in the pandemic.

A recent study suggests that incomplete antibiotic therapy should be avoided and that transition to oral antibiotics should be offered to people who inject drugs being treated for bacteremia who have declined the standard IV antibiotics

Patients with normal oxygenation levels who were treated for possible pneumonia experienced similar outcomes with an “ultrashort” course of antibiotics compared with a longer course, researchers reported recently.

People living with HIV were less likely to receive inappropriate antibiotics for acute respiratory infections compared with people without HIV, especially when treated by an HIV clinician, researchers found.

Many people who use drugs who are sent to skilled nursing facilities for outpatient parenteral antibiotic therapy do not complete treatment, according to findings from a single-center study published in Open Forum Infectious Diseases.

Three days of antibiotic therapy was noninferior to 8 days of therapy for patients with moderately severe community-acquired pneumonia, according to a study published in The Lancet.

ORLANDO — Augmentin is a good go-to antibiotic choice for ocular infections, according to Nate Lighthizer, OD, FAAO, during his presentation on oral treatments for anterior segment disease here at Vision Expo East.

The incidence of asthma in children declined 26% from 2000 to 2014 in British Columbia, Canada, and researchers have linked the decrease to reductions in early antibiotic exposure, mediated by changes in gut microbiota.

Use of two IV antipseudomonal antibiotics was not associated with improvement in clinical outcomes compared with one IV and one inhaled antibiotic in young patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection.